List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 218 studies with search of:   United States, Wyoming
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: TLK286 HCl for injection;   Drug: topotecan hydrochloride for injection;   Drug: doxorubicin HCl liposome injection
2 Active, not recruiting A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: peginterferon alfa-2a (40KD) [PEGASYS];   Drug: Copegus;   Drug: Copegus;   Drug: peginterferon alfa-2a (40KD) [PEGASYS]
3 Recruiting Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: letrozole;   Drug: placebo;   Drug: tamoxifen citrate
4 Recruiting Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Procedure: observation;   Procedure: radiation therapy
5 Recruiting Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition
Interventions: Drug: cyclophosphamide;   Drug: goserelin
6 Recruiting Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer;   Prostate Cancer
Interventions: Drug: placebo;   Drug: zoledronic acid
7 Recruiting Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: placebo
8 Recruiting Assessment and Tracking of Long-Term Alefacept Safety
Condition: Psoriasis
Intervention: Drug: Alefacept exposure
9 Active, not recruiting Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
Condition: Melanoma (Skin)
Interventions: Drug: everolimus;   Drug: temozolomide;   Procedure: flow cytometry;   Procedure: immunohistochemistry staining method;   Procedure: immunologic technique;   Procedure: reverse transcriptase-polymerase chain reaction
10 Recruiting Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Procedure: observation
11 Recruiting Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: vorinostat;   Procedure: conventional surgery
12 Recruiting Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: bevacizumab;   Drug: sorafenib tosylate;   Drug: temsirolimus
13 Recruiting Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Conditions: Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Pain;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: baclofen/amitriptyline/ketamine gel;   Drug: placebo
14 Completed Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
Condition: Non-Metastatic Prostate Cancer
Interventions: Drug: Bicalutamide;   Drug: Placebo
15 Completed Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients Who Are Undergoing Surgery for Liver Metastases Due to Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: bevacizumab;   Drug: capecitabine;   Drug: oxaliplatin;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
16 Recruiting Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition
Intervention: Procedure: quality-of-life assessment
17 Recruiting Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: clodronate disodium;   Drug: ibandronate sodium;   Drug: zoledronic acid
18 Recruiting Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Conditions: Breast Cancer;   Lung Cancer;   Metastatic Cancer;   Pain;   Prostate Cancer
Interventions: Drug: calcium carbonate;   Drug: calcium citrate;   Drug: calcium glucarate;   Drug: calcium gluconate;   Drug: samarium Sm 153 lexidronam pentasodium;   Drug: strontium chloride Sr 89;   Drug: vitamin D;   Drug: zoledronic acid
19 Recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Condition: Lung Cancer
Interventions: Drug: bevacizumab;   Drug: carboplatin;   Drug: cisplatin;   Drug: docetaxel;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Drug: vinorelbine ditartrate
20 Recruiting A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention:

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options